Hologic Overview
Hologic Target Price
Analysts' 12-month price predictions for HOLX.
Share Price
$57.12
Average Target Price
$65.00
13.8% upside
13.8% upside1 analysts in the last 4 months
High: $65 | Low: $65
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-05-05 | Morgan StanleyTejas Savant | $65 | 13.8% upside |  |
| 2024-11-05 | Mizuho SecuritiesAnthony Petrone | $87 | 52.3% upside | |
| 2024-10-04 | Mizuho SecuritiesAnthony Petrone | $90 | 57.6% upside | |
| 2024-10-01 | CitigroupPatrick Donnelly | $85 | 48.8% upside | |
| 2024-07-30 | NeedhamMike Matson | $90 | 57.6% upside | |
| 2024-07-02 | Evercore ISIVijay Kumar | $76 | 33.1% upside | |
| 2024-06-27 | OppenheimerIan Zaffino | $33 |  42.2% downside | |
| 2024-05-09 | Argus ResearchDavid Toung | $95 | 66.3% upside | |
| 2023-02-02 | Cowen & Co. | $95 | 66.3% upside | |
| 2023-01-10 | Wells Fargo | $80 | 40.1% upside | |
| 2022-12-07 | RBC Capital | $75 | 31.3% upside | |
| 2022-07-28 | Raymond James | $80 | 40.1% upside | |
| 2022-07-28 | Morgan Stanley | $70 | 22.5% upside | |
| 2022-05-17 | Leerink Partners | $85 | 48.8% upside | |
| 2022-04-28 | Citigroup | $75 | 31.3% upside | |
| 2022-04-28 | Raymond James | $83 | 45.3% upside | |
| 2022-04-28 | Leerink Partners | $82 | 43.6% upside | |
| 2022-04-25 | Wells Fargo | $75 | 31.3% upside | |
| 2022-04-06 | Evercore ISIVijay Kumar | $80 | 40.1% upside | |
| 2021-12-09 | JefferiesAnthony Petrone | $95 | 66.3% upside | |
| 2021-04-29 | UBSMichael Lasser | $77 | 34.8% upside | |